ࡱ> NPMq` $bjbjqPqP 4J:: |||||||8,T<HJJJJJJ$h#^n|n||^||HH|| 0DM  R0\F|"nn^d |||||| 1. HEME SYNTHESIS - heme is an iron containing prosthetic group found in hemoglobin, myoglobin, and cytochromes - heme binds O2, participates in electron transfer, or oxidizes exogenous molecule - reaction for synthesis occur both in cytoplasm and mitochondrial matrix; final step of pathway ( incorporation of iron (Fe2+) into molecule - delta-aminolevulinate synthase (delta-ALA synthase) is initial reaction in heme synthesis: combines succinyl CoA (carbon backbone) and glycine (nitrogen)( delta-aminolevulinic acid (delta-ALA); pyridoxal phosphate as a cofactor; committed, regulated step of porphyrin biosynthesis; mitochondrial reaction because succinyl CoA comes from citric acid cycle, amino acids, and odd-chain fatty acids via methylmalonyl CoA; delta-ALA transported from mitochondria ( cytoplasm - ALA dehydratase (8 subunits, in cytoplasm, zinc cofactor, lead inhibition) combines 2 molecules of delta-ALA ( porphobilinogen - uroporphyrinogen synthase/uroporphyrinogen cosynthase form uroporphyrinogen III by first combining 4 molecules of porphobilinogen ( uroporphyrinogen I via uroporphyrinogen synthase; then uroporphyrinogen I ( uroporphyrinogen III by uroporphyrinogen cosynthase - a decarboxylase form coproporphyrinogen III from uroporphyrinogen III; coproporphyrinogen III transported to mitochondria - two oxidase reactions convert coproporphyrinogen III to protoporphyrin IX (hydrophobic) - chelation of Fe2+ by ferrochelatase acting on protoporphyrin IX (in mitochondria); ferrochelatase required ascorbate (vitamin C) as a cofactor; enzyme inhibited by lead; defect in ferrochelatase ( accumulation of protoporphyrin IX ( its measurement in RBCs used to identify iron deficiency or lead poisoning; heme is final product in mitochondria - lead causes anemia due to inability to synthesize heme leading to reduction in functional RBCs Coordinated regulation of heme and globin synthesis - heme is the major feedback regulator of the pathway, Heme: 1.) inhibits activity of pre-existing delta-ALA synthase (important) 2.) diminishes transport of delta-ALA synthase from cytoplasm ( mitochondria after enzyme synthesis 3.) repressed production of delta-ALA synthase by regulating gene transcription 4.) stimulates globin synthesis to keep free heme levels low (important) Porphyrias are genetic deficiencies of enzymes in heme synthetic pathway; intermediates are photosensitive due to unsaturated, cyclic molecular structure TypeEnzyme involvedSymptomsLab TestsAcute intermittent porphyriaUroporphyrinogen synthaseAbdominal pain, neuropsychiatricIncreased urinary porphobilinogenCongenital erythropoietic porphyriaUroporphyrinogen CosynthasePhotosensitivity, dark urine, hemolytic anemia, cutaneous lesionsIncreased urinary uroporphyrinogen I, but no change in porphobilinogen (already converted)Erythropoietic protoporphyriaFerrochelatasePhotosensitivity Increased fecal protoporphyrin IX, red cell/plasma protoporphyrin IX 2. HEME CATABOLISM - RBC life is 120 days ( hemoglobin degraded; amino acids from globins and iron recycled; porphyrin is degraded ( bilirubin is end product of heme catabolism Blood cells - hemoglobin broken down to globin and heme - heme oxygenase converts heme backbone ( biliverdin IXalpha; produces carbon monoxide (CO) - biliverdin reductase (NADPH ( NADP+) converts biliverdin IXalpha ( bilirubin (not water soluble, unconjugated) ( bilirubin transported from reticuloendothelial cell in to plasma ( binds to albumin ( transported to hepatocyte (liver) via blood Liver - in hepatocyte ( UDP-glucuronyltransferase conjugates bilirubin with 2 molecules of glucuronic acid (derived from UDP-glucuronic acid) ( bilirubin diglucuronide (water soluble, conjugated) Post-hepatic metabolism - bilirubin diglucuronide excreted into bile duct to intestines - lumen of intestine ( bacterial enzymes act on conjugated bilirubin; first, glucuronic acid residues removed; then, bilirubin backbone reduced to urobilinogen; some urobilinogen absorbed by intestinal cells and set via blood to kidney where it is excreted in urine as urobilin (yellow urine color); most urobilinogen oxidized to stercobilin ( major excreted product from heme (brown color to feces) 3. - direct hyperbilirubinemia ( elevated levels of conjugated, water-soluble bilirubin - indirect hyperbilirubinemia ( elevated levels of unconjugated, water-insoluble bilirubin - mixed means elevation of both forms; jaundice ( yellow skin/eyes due to deposition of unconjugated bilirubin in skin and conjunctiva - disorders of bilirubin metabolism categorized into: increased production, decreased conjugation, and decreased excretion Hemolytic anemia - jaundice from hemolysis results from accelerated destruction of RBCs (hereditary spherocytosis, sickle cell disease, hemoglobin turnover in newborns) - production of bilirubin increases; no block in bilirubin conjugation and excretion ( bilirubin diglucuronide (conjugated) excreted into intestine increases; amount of bilirubin produced far exceeds conjugating capacity of liver ( unconjugated hyperbilirubinemia (in blood) - increased conjugated bilirubin released into bile duct (less increase than unconjugated form) - production of bilirubin-UDP glucuronyltransferase delayed in newborn infants ( physiologic jaundice during 1st week of life - unconjugated bilirubin deposited in skin ( UV light photolyzes unconjugated bilirubin to water soluble products - capacity of liver to conjugate bilirubin increases during first few days of life Hepatitis - liver damage ( destruction of hepatocytes; infectious hepatitis and acetaminophen poisoning - jaundice results from impaired capacity to conjugate and secrete bilirubin diglucuronide into bile - high levels of unconjugated bilirubin (in blood); residual hepatic capacity to conjugate bilirubin so a mixed hyperbilirubinemia is found ( occurs because not all of conjugated bilirubin can be excreted by the damaged hepatocytes causing it to exit cells into blood ( increased conjugated bilirubin in blood (equal to increase of unconjugated form) Obstruction of biliary passage - bile duct obstruction ( failure of bile to reach lumen of bowel; gallstone in lumen of bile duct - early stages ( liver function normal ( liver secretes conjugated bilirubin ( direct hyperbilirubinemia - prolonged biliary obstruction ( liver damage ( direct and indirect hyperbilirubinemia - stool is gray colored; conjugated bilirubin excreted in urine in large amounts - small increase in unconjugated bilirubin in blood - larger increase in conjugated bilirubin in blood 4. GENETIC DISORDERS - Crigler-Najjar syndrome ( inactivity of liver bilirubin-UDP glucuronyltransferase; patients have very high levels of unconjugated bilirubin; I and II types, II is less sever - unconjugated bilirubin is hydrophobic ( increases causes bilirubin to be deposited in lipid of brain ( neurologic damage called kernicterus; profound jaundice - Gilbert syndrome ( milder defect in bilirubin-UDP glucuronyltransferase; mildly increased level of unconjugated bilirubin; slight jaundice, illness - Dubin-Johnson syndrome ( defects of impaired biliary secretion (abnormal transport of conjugated bilirubin into biliary system) produces elevated levels of conjugated bilirubin; moderate jaundice     #/?w~  $ % ? A P Q T r s     * V l n {    ) - < M V X \ ] e g w ѺѺѺѺѺզѺѺѺ jhsShsS5h4H h4H5hsShsS5 hsSH* jhOhsShsS hsS5 h}D5h}Dh}D5H*h}Dh}D5hN h}D5>*h}DApQ R * + 3 4 NOjgdI~$$w    " 1 2 3 4 F G K L e k l   : K T j n  59EST̽൫h4Hh4H5H*h4Hh4H5 jh h 5h h 5 h4H5 jhOh4Hh4H jhsShsS5 hsS5hsShsS5hsSCTUfwxy %O "4:DERx6\`nο麶 hx25 h+hI~hI~ hI~5 jhvhv5hv hv5 hx2h4H h4H5>*hx2hx25hx2 h4H5h4H jhOh4HCAXkd$$Ifl\H$Z Z Z Z t0644 la$If @ABef  =>LM^_)*+4XdfpɸɰɰɰɸɫɓhT9hI~5 hT9hT9 hT95hT9 hT9>*hI~hI~5 jhOhI~ hI~5>*hI~ hI~5 h hx2h+h hx25 h 5h hx2hx2hx25 hx25:ABf^XXXX$Ifkda$$Ifl\H$Z Z Z Z t0644 la >M_^XXXX$Ifkd$$Ifl\H$Z Z Z Z t0644 laWXd^\\\\\\\\\kd#$$Ifl\H$Z Z Z Z t0644 la   ./01:]^z(-.<KZnopqǸ jhOha ha5hahaha>* ha>* hT9hT9 hT9H* hT95hT9 hI~5 jhOhT9hI~HDGHYefVygdqlm/CLdt 0=ITUVswy~Kkstu!"-3FHXYirؽض hqlm>* hqlm5>*hmEhqlmhqlm5 jhOhqlm hqlm5hqlm jhOh(h(h(5 h(5h( ha5haFr "7<EFGH_lm{%4=?Ldev %;?LdimhmEhmE5>*hmEhmE5hmEhmEH* jhOhmE h0@hmEh0@h0@5h0@ hmE5hmE jhOhqlm hqlm5hqlmhqlm5hqlmAAJWntx!5U`oy   ! 4 9 j k !!!7!K!X!ҴҾҾҴҴҾҩhqlm h0@hmE jhOh0@ h0@5 hmE5>*h0@h0@5h0@ jhmEhmE5hmEhmE5 jhOhmEh hmE5hmE@[ !o!!!!!!">##$$$$$$$$$$$gdqlmX!]!`!q!v!!!!!!!!!!!!!""""@"d"z""""""""""""""####*#=#>#@#P#Q#R#d#########󯠯 hI_hI_hI_hI_5 hI_h0@ hI_5 jhOhI_hI_h0@5 jhOh0@hqlm h0@5>* h0@h0@ h0@5h0@h0@5h0@hI_h0@hI_58###$$,$@$F$U$r$$$$$$$$$$$$$h:jh:U hI_hI_hI_ hI_5 jhI_hI_521h:pS/ =!"#$% _$$If!vh5Z 5Z 5Z 5Z #vZ :Vl t65Z _$$If!vh5Z 5Z 5Z 5Z #vZ :Vl t65Z _$$If!vh5Z 5Z 5Z 5Z #vZ :Vl t65Z _$$If!vh5Z 5Z 5Z 5Z #vZ :Vl t65Z @@@ NormalCJ_HaJmH sH tH DA@D Default Paragraph FontRi@R  Table Normal4 l4a (k@(No List4@4 SHeader  !4 @4 SFooter  !j@j x2 Table Grid7:V0JpQR*+34NOj   A B f  > M _ W X d DGHYefVy[o>00000000000000000000000000000 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 00000000000000000000000000000000000000000000000000@0I0@0I0@0I0@0I0I0  w TrX!#$ !#$A$"$lP\>~--009*urn:schemas-microsoft-com:office:smarttagsState9*urn:schemas-microsoft-com:office:smarttagsplace X`*=|0@Hg{6N2u   -$ Lt}D h$/Y'*+, {-V%/m/50x23<79ICz+D@DEEmE6FFyHSMlnMN4FO%P^{PX^p^^/_(H`"dl*fgtjlLmqlmoFp]puIvPvnHwJwvw~x.y&{|{}O~HDmi0MB!89{:CKUa"Mto&e4HS1I~T9 kI_vOa@_I-gv,$ M2%JMRfO#o( + j<(3z SLc8$=L(G\3<e(!B/Y+N  A B f  > M _ @\,@@UnknownGz Times New Roman5Symbol3& z Arial;Wingdings"1h$%%DV3DV342HX ?S2 Nishant Patel Nishant PatelOh+'0  < H T `lt|Nishant PatelNormalNishant Patel4Microsoft Office Word@F#@|!L @x) @.?@ABCDFGHIJKLORoot Entry FDM QData &1Table.WordDocument4JSummaryInformation(=DocumentSummaryInformation8ECompObjq  FMicrosoft Office Word Document MSWordDocWord.Document.89q